Robert Leasure Jr., President and CEO at BIOANALYTICAL SYSTEMS INC (BASI), bought 4,000 shares at $1.77 ($7K) on 2019-03-08, disclosed to the SEC on 2019-03-11.
Open-market purchase of $7k BASI by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| NOTV | SELL | 2025-02-20 | $562K | — | Filing → |
| NOTV | SELL | 2025-02-04 | $188K | — | Filing → |
| NOTV | BUY | 2024-01-25 | $15K | — | Filing → |